SCHEMBL6980872

SCHEMBL6980872

CNC(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(Cl)cc1)c1ccccc1)C(=O)N2

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PAK4 O96013 5/20 0.43
KDR P35968 4/20 0.42
IP6K1 Q92551 1/20 0.42
LRRK2 Q5S007 1/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
EPHX1 P07099 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.40
BACE1 P56817 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
TP53 P04637 2/20 0.39
MAPT P10636 2/20 0.39
GSK3B P49841 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982075 1.00 PAK4 (0.43) PAK4KDRIP6K1LRRK2NPC1
SCHEMBL6981480 0.92 PAK4 (0.42) PAK4BACE1TP53MAPTGSK3B
SCHEMBL6981475 0.92 PAK4 (0.42) PAK4BACE1TP53MAPTGSK3B
SCHEMBL7984576 0.89 KDR (0.45) PAK4KDRLRRK2NPC1ALDH1A1
SCHEMBL7984532 0.88 RAB9A (0.49) PAK4KDRLRRK2NPC1RAB9A
SCHEMBL6977915 0.87 PAK4 (0.42) PAK4KDRSMN1; SMN2
SCHEMBL7987909 0.87 PAK4 (0.42) PAK4KDRSMN1; SMN2
SCHEMBL7226408 0.87 LRRK2 (0.47) PAK4KDRIP6K1LRRK2NPC1
SCHEMBL7226405 0.87 LRRK2 (0.47) PAK4KDRIP6K1LRRK2NPC1
SCHEMBL7985455 0.87 JAK3 (0.44) PAK4KDRLRRK2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1071665-B1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-10-01 EP disclosed
EP-1071665-A1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES Boehringer Ingelheim Pharma KG (DE) 2001-01-31 EP disclosed
US-6169106-B1 ANTITUMOUR AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-01-02 US disclosed
WO-1999052869-A1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-10-21 WO disclosed